LENSAR Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
Globe Newswire (Tue, 31-Mar 6:00 AM ET)
FTC Pressure Halts Alcon-LENSAR Merger — What’s Next for LNSR and the Cataract Surgery Market?
Market Chameleon (Tue, 17-Mar 4:41 AM ET)
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
Business Wire (Mon, 16-Mar 4:57 PM ET)
LENSAR Announces Termination of Merger Agreement with Alcon Research, LLC
Globe Newswire (Mon, 16-Mar 4:35 PM ET)
LENSAR Provides Update on Pending Acquisition by Alcon
Globe Newswire (Wed, 25-Feb 5:00 PM ET)
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
Lensar trades on the NASDAQ stock market under the symbol LNSR.
As of April 13, 2026, LNSR stock price climbed to $5.92 with 62,874 million shares trading.
LNSR has a beta of 1.13, meaning it tends to be more sensitive to market movements. LNSR has a correlation of 0.08 to the broad based SPY ETF.
LNSR has a market cap of $70.65 million. This is considered a Micro Cap stock.
Last quarter Lensar reported $16 million in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.02.
In the last 3 years, LNSR traded as high as $17.31 and as low as $1.80.
The top ETF exchange traded funds that LNSR belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.
LNSR has underperformed the market in the last year with a price return of -55.8% while the SPY ETF gained +32.2%. LNSR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.8% and -2.5%, respectively, while the SPY returned -0.9% and +8.2%, respectively.
LNSR support price is $5.44 and resistance is $5.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LNSR shares will trade within this expected range on the day.